A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.
Pancreatic surgery is not uncommonly complicated by prolonged pancreatic drainage and fistula. Octreotide decreases pancreatic exocrine function and has been reported to improve closure of pancreatic and intestinal fistulae. This randomized, prospective trial was designed to evaluate the efficacy of postoperative octreotide in reducing pancreatic drainage and complications after resection of neuroendocrine tumors of the pancreas.
Version: za2963e q8za4 q8zb9 q8zcf q8zd8 q8zef q8zf6 q8zg7